# Evaluation of Low Source of Signal in SCOUT DS

> **NCT01339637** · — · COMPLETED · sponsor: **VeraLight, Inc.** · enrollment: 196 (actual)

## Conditions studied

- Metabolic Syndrome
- Impaired Glucose Tolerance
- Gestational Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01339637
- **Lead sponsor:** VeraLight, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-09
- **Final completion:** 2011-10
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2012-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01339637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01339637, "Evaluation of Low Source of Signal in SCOUT DS". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01339637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*